Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. [electronic resource]
Producer: 20191213ISSN:- 2379-3708
- Adolescent
- Adult
- Aged
- Anti-HIV Agents -- pharmacology
- CD4-Positive T-Lymphocytes -- drug effects
- Dendritic Cells -- drug effects
- Drug Evaluation, Preclinical
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Interleukins -- immunology
- Jurkat Cells
- Lipopeptides -- pharmacology
- Male
- Middle Aged
- Primary Cell Culture
- Pteridines -- pharmacology
- Toll-Like Receptor 2 -- agonists
- Toll-Like Receptor 7 -- agonists
- Virus Activation -- drug effects
- Virus Latency -- drug effects
- Young Adult
- Interleukin-22
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.